We had a record year in FY 2008, which just closed. While all of the revenue numbers for the year will be included in the year end reports that are being compiled, I would like to point out that in the last quarter alone we sold or leased 11 units, and we have a backlog going into the new Fiscal Year. Indeed, we are benefiting from greater industry awareness about us. At the same time, we have signed up high-profile and respected distributors in Europe and in the Middle East. We are currently represented in France, Spain, Portugal, Italy, United Kingdom, Kuwait, UAE, Qatar and Bahrain, and have units installed in the United Kingdom, as well. Clinical trials are continuing at several international flagship hospitals. And we are accelerating our global expansion, and expect to have distributors in more countries in the months ahead. Our future plans are busy and exciting. First, the ValiMed family is expanding. At the upcoming American Society of Health-System Pharmacists meeting in Orlando, we will introduce the next generation of the ValiMed product line: • The CCT model will become our top of the line flagship unit, with the existing VM model still being used in certain applications. The new model incorporates technical advances and new capabilities in a smaller and lighter package. It has total configuration flexibility with a large medication signature capacity. It encompasses all the proven features of the ValiMed technology, but also provides new capabilities, such as comprehensive reporting tools and networking to name two new features. • In addition to the CCT, we will be launching new dedicated models for either narcotics control or drug admixtures testing at different price points to serve the needs of smaller hospitals around the world. • Finally we will also introduce a ValiMed device dedicated to training only. This is a tool that hospitals have desired to improve training methods and proficiency of pharmacy technicians. In short, the ValiMed product line now can be better customized to serve customer needs, providing compelling value at reasonable prices. This adaptability makes our product relevant in most healthcare market segments and available to an expanding group of geographical markets around the world. Secondly, we are making sure that our installation and customer service teams grow in size and capability to meet the growing demand for support and assistance to our customers. It is critical that CDEX and our Distributors continue to provide world class training and technical support as we increase our global market penetration. In closing, the Medical Safety Division of CDEX is making a major impact on hospital safety through its broadened product line, extensive geographical coverage and expanded training and customer support. Truly, we are making a difference and saving lives. It is for me a privilege to lead and manage the Medication Safety Division of CDEX Inc and I believe we have a bright future ahead of us.
News 
Market Data 
Discover 
